Analysis of Percutaneous Ablations for Cancer Treatment
| Status: | Completed |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 10/2/2013 |
| Start Date: | February 2012 |
| End Date: | December 2015 |
| Contact: | Maria V Rivas |
| Email: | mrivas2@emory.edu |
| Phone: | (404)712-7962 |
Prospective Analysis of Percutaneous Ablations for Cancer Treatment
This is a study involving patients with cancer who are referred by their treating physician
for percutaneous locoregional therapies.
Patient's clinical and radiology findings, pathology findings, survival, treatment
responses, and complications after their locoregional therapy will be studied.
The efficacy of the percutaneous and transarterial treatments for solid tumors will be
studied. Prospective study on patients who receive percutaneous locoregional therapies,
including radiofrequency ablation (RFA), cryoablation, microwave ablation, IRE and chemical
ablation for treatment of cancer will be performed.
Preoperative clinic chart, procedure note, postoperative chart, pre- and post-operative CT,
MRI or Ultrasound, angiographic findings, biopsy results and pathologic findings, will be
reviewed. Patient survival, treatment responses, complications after the therapy will be
collected from clinic visits and clinical encounters.
Patient overall performance status before and after procedures will be assessed using the
Quality of Life questionnaire (SF-36™ Health Survey).
Inclusion Criteria:
- 18yrs of age
- Cancer diagnosis
- Candidate for Locoregional therapy
- Willingness to sign informed consent
Exclusion Criteria:
- Unable to sign informed consent
- Patients not eligible for locoregional therapies
We found this trial at
1
site
Emory University Hospital As the largest health care system in Georgia and the only health...
Click here to add this to my saved trials
